The purpose of this study is to compare the usual treatment, which consists of chemotherapy alone, to chemotherapy plus the addition of radiation.
Learn more about the ECOG/ACRIN-EA2183 trial or call the Reading Hospital Cancer Research Office at 484-628-8193.
